National Vision (EYE)
(Delayed Data from NSDQ)
$13.20 USD
-0.38 (-2.80%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $13.20 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
EYE 13.20 -0.38(-2.80%)
Will EYE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EYE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EYE
Should Value Investors Buy National Vision (EYE) Stock?
EYE vs. PODD: Which Stock Is the Better Value Option?
EYE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings?
Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?
Are Investors Undervaluing National Vision (EYE) Right Now?
Other News for EYE
National Vision Appoints Caitlin Zulla to Board of Directors
Nova Eye Medical Issues New Employee Incentives
Nova Eye Medical Expands Share Offerings
National Vision Holdings Appoints New Director, Expands Board
Eagle Eye Solutions Major Shareholding Update